• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性可免受铁过载心肌病的影响,与铁代谢无关:氧化应激的关键作用。

Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.

作者信息

Das Subhash K, Patel Vaibhav B, Basu Ratnadeep, Wang Wang, DesAulniers Jessica, Kassiri Zamaneh, Oudit Gavin Y

机构信息

Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.

出版信息

J Am Heart Assoc. 2017 Jan 23;6(1):e003456. doi: 10.1161/JAHA.116.003456.

DOI:10.1161/JAHA.116.003456
PMID:28115312
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5523622/
Abstract

BACKGROUND

Sex-related differences in cardiac function and iron metabolism exist in humans and experimental animals. Male patients and preclinical animal models are more susceptible to cardiomyopathies and heart failure. However, whether similar differences are seen in iron-overload cardiomyopathy is poorly understood.

METHODS AND RESULTS

Male and female wild-type and hemojuvelin-null mice were injected and fed with a high-iron diet, respectively, to develop secondary iron overload and genetic hemochromatosis. Female mice were completely protected from iron-overload cardiomyopathy, whereas iron overload resulted in marked diastolic dysfunction in male iron-overloaded mice based on echocardiographic and invasive pressure-volume analyses. Female mice demonstrated a marked suppression of iron-mediated oxidative stress and a lack of myocardial fibrosis despite an equivalent degree of myocardial iron deposition. Ovariectomized female mice with iron overload exhibited essential pathophysiological features of iron-overload cardiomyopathy showing distinct diastolic and systolic dysfunction, severe myocardial fibrosis, increased myocardial oxidative stress, and increased expression of cardiac disease markers. Ovariectomy prevented iron-induced upregulation of ferritin, decreased myocardial SERCA2a levels, and increased NCX1 levels. 17β-Estradiol therapy rescued the iron-overload cardiomyopathy in male wild-type mice. The responses in wild-type and hemojuvelin-null female mice were remarkably similar, highlighting a conserved mechanism of sex-dependent protection from iron-overload-mediated cardiac injury.

CONCLUSIONS

Male and female mice respond differently to iron-overload-mediated effects on heart structure and function, and females are markedly protected from iron-overload cardiomyopathy. Ovariectomy in female mice exacerbated iron-induced myocardial injury and precipitated severe cardiac dysfunction during iron-overload conditions, whereas 17β-estradiol therapy was protective in male iron-overloaded mice.

摘要

背景

在人类和实验动物中,心脏功能和铁代谢存在性别差异。男性患者和临床前动物模型更容易患心肌病和心力衰竭。然而,在铁过载性心肌病中是否存在类似差异尚不清楚。

方法与结果

分别对雄性和雌性野生型及遗传性血色素沉着症小鼠注射并给予高铁饮食,以诱导继发性铁过载和遗传性血色素沉着症。雌性小鼠完全免受铁过载性心肌病的影响,而基于超声心动图和有创压力-容积分析,铁过载导致雄性铁过载小鼠出现明显的舒张功能障碍。尽管心肌铁沉积程度相当,但雌性小鼠铁介导的氧化应激受到显著抑制,且无心肌纤维化。去卵巢的铁过载雌性小鼠表现出铁过载性心肌病的基本病理生理特征,包括明显的舒张和收缩功能障碍、严重的心肌纤维化、心肌氧化应激增加以及心脏病标志物表达增加。去卵巢阻止了铁诱导铁蛋白的上调,降低了心肌肌浆网钙ATP酶2a水平,并增加了钠钙交换体1水平。17β-雌二醇治疗可挽救雄性野生型小鼠的铁过载性心肌病。野生型和遗传性血色素沉着症雌性小鼠的反应非常相似,但突出了性别依赖性保护免受铁过载介导的心脏损伤的保守机制。

结论

雄性和雌性小鼠对铁过载介导的心脏结构和功能影响反应不同,雌性明显免受铁过载性心肌病的影响。雌性小鼠去卵巢加剧了铁诱导的心肌损伤,并在铁过载条件下引发严重的心脏功能障碍,而17β-雌二醇治疗对雄性铁过载小鼠具有保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/51ed83f1100f/JAH3-6-e003456-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/def61c13df94/JAH3-6-e003456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/57a3e8e6d010/JAH3-6-e003456-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/a76a0afd377a/JAH3-6-e003456-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/cbf9d171c710/JAH3-6-e003456-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/f0a1281201d0/JAH3-6-e003456-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/ef17579d14d9/JAH3-6-e003456-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/04e08e9212b5/JAH3-6-e003456-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/392d734b030f/JAH3-6-e003456-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/28b87d5f383c/JAH3-6-e003456-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/c34526a9d413/JAH3-6-e003456-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/641c4a2f587a/JAH3-6-e003456-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/6326e879d4f0/JAH3-6-e003456-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/a1df446e51ae/JAH3-6-e003456-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/0c2f02fb85cd/JAH3-6-e003456-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/b88fcafaa04a/JAH3-6-e003456-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/51ed83f1100f/JAH3-6-e003456-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/def61c13df94/JAH3-6-e003456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/57a3e8e6d010/JAH3-6-e003456-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/a76a0afd377a/JAH3-6-e003456-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/cbf9d171c710/JAH3-6-e003456-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/f0a1281201d0/JAH3-6-e003456-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/ef17579d14d9/JAH3-6-e003456-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/04e08e9212b5/JAH3-6-e003456-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/392d734b030f/JAH3-6-e003456-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/28b87d5f383c/JAH3-6-e003456-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/c34526a9d413/JAH3-6-e003456-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/641c4a2f587a/JAH3-6-e003456-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/6326e879d4f0/JAH3-6-e003456-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/a1df446e51ae/JAH3-6-e003456-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/0c2f02fb85cd/JAH3-6-e003456-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/b88fcafaa04a/JAH3-6-e003456-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ba4/5523622/51ed83f1100f/JAH3-6-e003456-g016.jpg

相似文献

1
Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.女性可免受铁过载心肌病的影响,与铁代谢无关:氧化应激的关键作用。
J Am Heart Assoc. 2017 Jan 23;6(1):e003456. doi: 10.1161/JAHA.116.003456.
2
Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.基因敲除小鼠模型的铁过载性心肌病经白藜芦醇治疗后得到挽救。
Biosci Rep. 2018 Jan 10;38(1). doi: 10.1042/BSR20171302. Print 2018 Feb 28.
3
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.白藜芦醇疗法可减轻获得性和遗传性模型中的铁过载损伤及心肌病。
Sci Rep. 2015 Dec 7;5:18132. doi: 10.1038/srep18132.
4
TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.TIMP3 缺乏加剧铁过载介导的心肌病和肝病。
Am J Physiol Heart Circ Physiol. 2018 May 1;314(5):H978-H990. doi: 10.1152/ajpheart.00597.2017. Epub 2018 Jan 26.
5
L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy.L型钙离子通道是铁过载心肌病中铁进入心肌细胞的主要途径。
Nat Med. 2003 Sep;9(9):1187-94. doi: 10.1038/nm920. Epub 2003 Aug 24.
6
Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload.肝特异性β-catenin 缺失的小鼠在铁过载后会发生脂肪性肝炎和肝纤维化。
J Hepatol. 2017 Aug;67(2):360-369. doi: 10.1016/j.jhep.2017.03.012. Epub 2017 Mar 22.
7
Loss of ADAM15 in female mice does not worsen pressure overload cardiomyopathy, independent of ovarian hormones.在不考虑卵巢激素的情况下,缺失 ADAM15 的雌性小鼠的压力超负荷性心肌病并未恶化。
Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H409-H416. doi: 10.1152/ajpheart.00116.2024. Epub 2024 Apr 12.
8
Loss of NOX2 (gp91phox) prevents oxidative stress and progression to advanced heart failure.NOX2(gp91phox)缺失可防止氧化应激和进展为晚期心力衰竭。
Clin Sci (Lond). 2014 Sep;127(5):331-40. doi: 10.1042/CS20130787.
9
Ablation Is Associated With Increased Nitro-Oxidative Stress During Ischemia-Reperfusion Injury: Implications for Human Ischemic Cardiomyopathy.消融与缺血再灌注损伤期间硝基氧化应激增加相关:对人类缺血性心肌病的影响。
Circ Heart Fail. 2017 Feb;10(2). doi: 10.1161/CIRCHEARTFAILURE.116.003523.
10
mRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overload.铁过载小鼠模型中心脏铁转运蛋白和铁蛋白亚基的mRNA调控
Exp Hematol. 2014 Dec;42(12):1059-67. doi: 10.1016/j.exphem.2014.09.002. Epub 2014 Sep 16.

引用本文的文献

1
Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism.帕金通过泛素化ACSL4和调节多不饱和脂肪酸-磷脂代谢来抑制铁过载诱导的心肌细胞铁死亡。
Acta Pharm Sin B. 2025 Mar;15(3):1589-1607. doi: 10.1016/j.apsb.2024.12.027. Epub 2025 Jan 2.
2
Phospholipids and peroxisomes in ferroptosis: the therapeutic target of acupuncture regulating vascular cognitive impairment and dementia.铁死亡中的磷脂与过氧化物酶体:针刺调节血管性认知障碍和痴呆的治疗靶点
Front Aging Neurosci. 2025 Apr 29;17:1512980. doi: 10.3389/fnagi.2025.1512980. eCollection 2025.
3

本文引用的文献

1
Rescue of Pressure Overload-Induced Heart Failure by Estrogen Therapy.雌激素疗法对压力超负荷诱导的心力衰竭的挽救作用。
J Am Heart Assoc. 2016 Jan 22;5(1):e002482. doi: 10.1161/JAHA.115.002482.
2
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.白藜芦醇疗法可减轻获得性和遗传性模型中的铁过载损伤及心肌病。
Sci Rep. 2015 Dec 7;5:18132. doi: 10.1038/srep18132.
3
Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences.氧化还原纤维化:转化生长因子β1对活性氧生成器、介质及功能后果的影响
Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation.
普拉梭菌通过丁酸介导的LCN2调节抑制心肌细胞铁死亡,从而预防与年龄相关的心力衰竭。
Gut Microbes. 2025 Dec;17(1):2505119. doi: 10.1080/19490976.2025.2505119. Epub 2025 May 13.
4
Iron chelating, antioxidant and anti-apoptotic activities of hesperidin and/or rutin against induced-ferroptosis in heart tissue of rats.橙皮苷和/或芦丁对大鼠心脏组织诱导性铁死亡的铁螯合、抗氧化和抗凋亡活性。
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251331873. doi: 10.1177/03946320251331873. Epub 2025 Apr 9.
5
An emerging double‑edged sword role of ferroptosis in cardiovascular disease (Review).铁死亡在心血管疾病中双重作用的研究进展(综述)。
Int J Mol Med. 2025 Jan;55(1). doi: 10.3892/ijmm.2024.5457. Epub 2024 Nov 14.
6
Association between dietary intake of iron and heart failure among American adults: data from NHANES 2009-2018.美国成年人铁摄入量与心力衰竭之间的关联:来自2009 - 2018年美国国家健康与营养检查调查(NHANES)的数据。
BMC Nutr. 2024 Nov 11;10(1):148. doi: 10.1186/s40795-024-00957-4.
7
Scientific opinion on the tolerable upper intake level for iron.关于铁的可耐受最高摄入量的科学意见。
EFSA J. 2024 Jun 12;22(6):e8819. doi: 10.2903/j.efsa.2024.8819. eCollection 2024 Jun.
8
Ferroptosis contributing to cardiomyocyte injury induced by silica nanoparticles via miR-125b-2-3p/HO-1 signaling.铁死亡通过 miR-125b-2-3p/HO-1 信号通路促进二氧化硅纳米颗粒诱导的心肌细胞损伤。
Part Fibre Toxicol. 2024 Apr 1;21(1):17. doi: 10.1186/s12989-024-00579-5.
9
Amlodipine rescues advanced iron overload cardiomyopathy in hemojuvelin knockout murine model: Clinical implications.氨氯地平挽救血色素沉着症相关蛋白基因敲除小鼠模型中的晚期铁过载心肌病:临床意义。
Front Cardiovasc Med. 2023 Apr 21;10:1129349. doi: 10.3389/fcvm.2023.1129349. eCollection 2023.
10
Protein Susceptibility to Peroxidation by 4-Hydroxynonenal in Hereditary Hemochromatosis.遗传性血色素沉着症中 4-羟壬烯醛导致的蛋白质易氧化性。
Int J Mol Sci. 2023 Feb 2;24(3):2922. doi: 10.3390/ijms24032922.
Redox Biol. 2015 Dec;6:344-352. doi: 10.1016/j.redox.2015.08.015. Epub 2015 Aug 28.
4
Increased Heme Levels in the Heart Lead to Exacerbated Ischemic Injury.心脏中血红素水平升高会导致缺血性损伤加剧。
J Am Heart Assoc. 2015 Jul 31;4(8):e002272. doi: 10.1161/JAHA.115.002272.
5
Iron and oxidative stress in cardiomyopathy in thalassemia.地中海贫血性心肌病中铁和氧化应激。
Free Radic Biol Med. 2015 Nov;88(Pt A):3-9. doi: 10.1016/j.freeradbiomed.2015.07.019. Epub 2015 Jul 26.
6
Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications.氧化应激在收缩性和舒张性心力衰竭中的病理生理作用及其治疗意义。
Eur Heart J. 2015 Oct 7;36(38):2555-64. doi: 10.1093/eurheartj/ehv305. Epub 2015 Jul 4.
7
Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload.白藜芦醇在铁过载的获得性和遗传性小鼠模型中介导肝脏治疗作用。
Liver Int. 2016 Feb;36(2):246-57. doi: 10.1111/liv.12893. Epub 2015 Jul 3.
8
Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.雌激素通过雌激素反应元件调控铁转运蛋白信号传导,从而有助于调节铁代谢。
Cell Signal. 2015 May;27(5):934-42. doi: 10.1016/j.cellsig.2015.01.017. Epub 2015 Feb 4.
9
PI3Kα is essential for the recovery from Cre/tamoxifen cardiotoxicity and in myocardial insulin signalling but is not required for normal myocardial contractility in the adult heart.PI3Kα 对于 Cre/tamoxifen 心脏毒性的恢复和心肌胰岛素信号传导至关重要,但在成年心脏中并不需要正常的心肌收缩力。
Cardiovasc Res. 2015 Mar 1;105(3):292-303. doi: 10.1093/cvr/cvv016. Epub 2015 Jan 24.
10
Role of heme in cardiovascular physiology and disease.血红素在心血管生理学和疾病中的作用。
J Am Heart Assoc. 2015 Jan 5;4(1):e001138. doi: 10.1161/JAHA.114.001138.